[HTML][HTML] Return on investment in science: twenty years of European Commission funded research in Alzheimer's dementia, breast cancer and prostate cancer
M Jakovljevic, P Deceuninck, F Pistollato… - Cost Effectiveness and …, 2024 - Springer
Abstract Alzheimer's disease (AD), breast cancer (BC) and prostate cancer (PC) continue to
be high in the research and innovation agenda of the European Commission (EC). This is …
be high in the research and innovation agenda of the European Commission (EC). This is …
[HTML][HTML] Return on investment in science: twenty years of European Commission funded research in Alzheimer's dementia, breast cancer and prostate cancer
M Jakovljevic, P Deceuninck… - Cost …, 2024 - resource-allocation.biomedcentral …
Alzheimer's disease (AD), breast cancer (BC) and prostate cancer (PC) continue to be high
in the research and innovation agenda of the European Commission (EC). This is due to …
in the research and innovation agenda of the European Commission (EC). This is due to …
Return on investment in science: twenty years of European Commission funded research in Alzheimer's dementia, breast cancer and prostate cancer
M Jakovljevic, P Deceuninck… - … allocation: C/E, 2024 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD), breast cancer (BC) and prostate cancer (PC) continue to be high
in the research and innovation agenda of the European Commission (EC). This is due to …
in the research and innovation agenda of the European Commission (EC). This is due to …
[HTML][HTML] Return on investment in science: twenty years of European Commission funded research in Alzheimer's dementia, breast cancer and prostate cancer
M Jakovljevic, P Deceuninck, F Pistollato… - … Allocation: C/E, 2024 - ncbi.nlm.nih.gov
Abstract Alzheimer's disease (AD), breast cancer (BC) and prostate cancer (PC) continue to
be high in the research and innovation agenda of the European Commission (EC). This is …
be high in the research and innovation agenda of the European Commission (EC). This is …
[PDF][PDF] Return on investment in science: twenty years of European Commission funded research in Alzheimer's dementia, breast cancer and prostate cancer
M Jakovljevic, P Deceuninck… - Cost …, 2024 - resource-allocation.biomedcentral …
Abstract Alzheimer's disease (AD), breast cancer (BC) and prostate cancer (PC) continue to
be high in the research and innovation agenda of the European Commission (EC). This is …
be high in the research and innovation agenda of the European Commission (EC). This is …